Polyrizon completes safety tests for NASARIX nasal spray
Polyrizon (NASDAQ:PLRZ) said it has completed the biocompatibility evaluation program for its NASARIX™ Allergy Blocker nasal spray.
Polyrizon (NASDAQ:PLRZ) said it has completed the biocompatibility evaluation program for its NASARIX™ Allergy Blocker nasal spray.
CME Group (NASDAQ:CME) reported record average daily volume of 30.6 million contracts for June 2026, marking a 19% increase compared with the same period last year.
Obsidian Energy (NYSE:OBE) said it has closed its Belly River light oil acquisition in Willesden Green for approximately $98 million.
Dole (NYSE:DOLE) said its subsidiary Dole Nordic AB has completed the acquisition of Greenfood AB’s Fresh Produce division, known as GFP.
VERAXA Biotech (NASDAQ:VRXA) said it has begun cell line development for its lead BiTAC T-cell engager (BiTAC-TCE) candidate.
Alliance Resource Partners (NASDAQ:ARLP) completed its $206.2 million acquisition of oil and gas mineral interests to expand its portfolio.
Arcturus Therapeutics Holdings (NASDAQ:ARCT) announced a strategic collaboration with Thermo Fisher Scientific (NYSE:TMO) to support Phase 3 development and potential commercialization of ARCT-032, its investigational mRNA therapy for cystic fibrosis.
UMH Properties (NYSE:UMH) reported preliminary second-quarter 2026 operating metrics showing total rental and related income increased 10.3% year over year.
Lindsay (NYSE:LNN) reported third-quarter fiscal 2026 revenue of $160.8 million, a 5% decline from $169.5 million in the same period last year.
GFL Environmental (NYSE:GFL) declared a cash dividend of $0.0169 per share for the second quarter of 2026.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy